Synthesis and analysis of 2-[211At]-L-phenylalanine and 4-[211At]-L-phenylalanine and their uptake in human glioma cell cultures in-vitro

Appl Radiat Isot. 2010 Jun;68(6):1060-5. doi: 10.1016/j.apradiso.2009.12.043. Epub 2010 Jan 13.

Abstract

2-[211At]-L-phenylalanine and 4-[211At]-L-phenylalanine were prepared from the corresponding iodo and bromo derivatives using the Cu(+)-assisted nucleophilic exchange. 4-[211At]-L-phenylalanine was additionally prepared by destannylation of the BOC-derivatized 4-tributylstannyl-L-phenylalanine. Radiochemical yields of 2-[211At]-L-phenylalanine and 4-[211At]-L-phenylalanine by nucleophilic exchange were 52-74% and 65-85%. Radiochemical yield of 4-[211At]-L-phenylalanine by electrophilic destannylation was 35-50%. HPLC sequence analysis showed that 2-[211At]-L-phenylalanine followed the halogen sequence (F<Cl<Br<I<At) whereas 4-[211At]-L-phenylalanine eluted between 4-Br-L-phenylalanine and 4-I-L-phenylalanine (F<Cl<Br<At<I), independent on the production pathway. Uptake of 4-[211At]-L-phenylalanine and 4-[131I]-L-phenylalanine in DBTRG-05MG glioma cells was inhibited by l-phenylalanine 7-fold and 6-fold, respectively.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Astatine*
  • Brain Neoplasms / metabolism*
  • Cell Line, Tumor
  • Glioma / metabolism*
  • Humans
  • Isotope Labeling / methods*
  • Phenylalanine / analogs & derivatives*
  • Phenylalanine / metabolism
  • Radiopharmaceuticals / metabolism*

Substances

  • Radiopharmaceuticals
  • Phenylalanine
  • Astatine